Central but not peripheral opiate receptor blockade prolonged pituitary-adrenal responses to stress

https://doi.org/10.1016/0091-3057(90)90386-VGet rights and content

Abstract

Evidence from pharmacological studies suggests that opiate systems may serve either inhibitory or stimulatory functions on stress-induced reponses of the hypothalamic-pituitary-adrenocortical (HPA) axis. The objective of these experiments was to determine whether these discrepant findings may result, in part, from differential effects of central or peripheral opiate receptor blockade on HPA axis responses. To this effect, groups of rats received injections of either saline, naltrexone (NHCl) or the quaternary analogue naltrexone methobromide (NMBr). The animals were then exposed to 30 min of a motion stressor and blood samples were obtained from each rat for analysis of ACTH, corticosterone, and prolactin. The data showed that resting and stress-induced levels of prolactin were decreased by NHCl only. Although neither drug affected the magnitude of the stress-induced ACTH and corticosterone responses, treatment with NHCl, but not NMBr, delayed the poststress decline of these responses. Hence, we concluded that central opiate mechanisms may be important for cessation of HPA axis activity, after exposure to stressful situations.

References (35)

  • T.W. Smith et al.

    Peripheral antinociceptive effects of N-methylmorphine

    Life Sci.

    (1982)
  • A. Spiaggia et al.

    Opiate and non-opiate mechanisms of stress-induced analgesia: Cross tolerance between stressors

    Pharmacol. Biochem. Behav.

    (1979)
  • W.W. Tapp et al.

    Effects of naloxone on corticosterone response to stress

    Pharmacol. Biochem. Behav.

    (1981)
  • D.A. Van Vugt et al.

    Naloxone inhibition of stress-induced increase in prolactin secretion

    Life Sci.

    (1978)
  • L.R. Watkins et al.

    Opiate vs non-opiate footshock-induced analgesia (FSIA): The body region shocked is a critical factor

    Brain Res.

    (1982)
  • E.D. Abercrombie et al.

    Systemic naloxone administration potentiates locus coeruleus noradrenergic neuronal activity under stressful but not non-stressful conditions

    Brain Res.

    (1988)
  • A. Brodish et al.

    Age-dependent effects of chronic stress on ACTH and corticosterone responses to an acute novel stress

    Neuroendocrinology

    (1989)
  • Cited by (26)

    • The opioid system in stress-induced memory disorders: From basic mechanisms to clinical implications in post-traumatic stress disorder and Alzheimer's disease

      2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry
      Citation Excerpt :

      (B) Opioid antagonists might affect the activity of the HPA axis during stress, and therefore, modify plasma corticosterone levels. For instance, naloxone or naltrexone can enhance or reduce corticosterone release after acute stress depending on the type of stressor (i.e. forced swimming, cold water, acute motion stress) (Douglas et al., 1998; Odio and Brodish, 1990; Retana-Márquez et al., 2009). Moreover, the highly selective k receptor agonist, U-50488H, but not μ and δ agonists, stimulates ACTH and cortisol release in rhesus monkeys, an effect that is blocked by the k antagonist, nor-Binaltorphimine (Pascoe et al., 2008).

    • Changes in adaptability following perinatal morphine exposure in juvenile and adult rats

      2011, European Journal of Pharmacology
      Citation Excerpt :

      Endorphins and related peptides are found throughout the CNS and have profound effects on neuroendocrine function. Evidences from pharmacological studies suggest that the opiate system may have both inhibitory and stimulatory functions on the HPA axis (Odio and Brodish, 1990). In humans, heretofore, only the inhibitory action of endogenous opioids or orally administered opiates has been demonstrated (Allolio et al., 1987; Grossman et al., 1986; Taylor et al., 1986; Zhang et al., 2008).

    • Limited effects of β-endorphin compared to loperamide or fentanyl in a neuroendocrine biomarker assay in non-human primates

      2008, Psychoneuroendocrinology
      Citation Excerpt :

      It cannot be excluded that a larger dose of quaternary naltrexone could have produced full blockade of fentanyl in this setting (such a dose could not be studied, due to supply limitations). However, it is possible that in addition to hypothalamic sites functionally outside the blood–brain barrier, μ-agonists may also cause prolactin release in primates by acting at sites inside the blood–brain barrier (consistent with some findings in rodents) (Armstrong and Hatton, 1980; Panerai et al., 1981; Odio and Brodish, 1990; Merchenthaler, 1991). The observed full blockade of fentanyl's effect by nalmefene (which would be postulated to occupy μ-receptors both inside and outside the blood–brain barrier) is consistent with the latter interpretation (France and Gerak, 1994; Butelman et al., 2002).

    • Neuroendocrine pharmacology of stress

      2003, European Journal of Pharmacology
    View all citing articles on Scopus
    View full text